Login / Signup

Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis.

Mark C KorpicsWilliam Tyler TurchanMatthew KoshyMichael T Spiotto
Published in: Head & neck (2022)
Compared to chemoRT or RTonly, cetuxRT is associated with decreased OS for patients with HNSCC, suggesting minimal benefit of bioradiotherapy in this population.
Keyphrases
  • locally advanced
  • rectal cancer
  • neoadjuvant chemotherapy
  • squamous cell carcinoma
  • radiation therapy
  • phase ii study
  • clinical trial
  • free survival
  • early stage
  • radiation induced
  • study protocol